MedTrace Logo

Melatonin Decreases Eye Pressure in Normotensive Patients

NCT03193112 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2018-08-13

No results posted yet for this study

Summary

Agomelatine is a melatonin drug used to treat depressive disorder. Agomelatine may also some effects on ocular pressures. In this study, we aimed to demonstrate that melatonin decreases intraocular pressures when given depressive patients.

Conditions

  • Depressive Disorder

Interventions

DRUG

Agomelatine 25 MG Oral Tablet

We will treat our patients with Agomelatine tablet of 25 mg.

Sponsors & Collaborators

  • Kahramanmaras Sutcu Imam University

    lead OTHER

Principal Investigators

  • Gokhan Ozdemir, MD · KSU

Eligibility

Min Age
18 Years
Max Age
66 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-16
Primary Completion
2017-10-15
Completion
2018-06-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03193112 on ClinicalTrials.gov